WHO urges Ervebo vaccine trial in DR Congo Ebola outbreak
Summary
The World Health Organization (WHO) has recommended starting a large human trial of the Ervebo vaccine in the Democratic Republic of Congo (DR Congo). This trial aims to find out if the vaccine can protect people against a new deadly strain of Ebola spreading in the area.Key Facts
- The WHO’s vaccine experts made this recommendation on a Friday.
- Ervebo is the only existing Ebola vaccine that is officially approved.
- The trial is planned to test if Ervebo can protect against a new strain of the Ebola virus.
- The outbreak is currently happening in DR Congo.
- Ebola is a serious disease that can cause severe illness and death.
- The trial involves vaccinating people to see how well the vaccine works against this strain.
- The goal is to have a vaccine available for the public to control the outbreak.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
